ArticleBMJ public health2026
"I would walk through fire to get this vaccine": a mixed-methods study examining attitudes and perceptions of a gonorrhoea vaccine programme among UK sexual health service users.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Antimicrobial-resistant gonorrhoea poses a significant global public health threat. In response, the UK launched the world's first gonorrhoea vaccination programme using a 4CMenB vaccine, targeting individuals at high risk of bacterial sexually transmitted infections (STIs). Understanding attitudes and acceptability among sexual health service users is essential to inform successful implementation. Methods: The NAVIGATE study employed a mixed-methods design, combining an online survey (n=395) with semi-structured interviews (n=15) among UK adults who had previously accessed sexual health services. The survey included demographic questions, the validated Vaccination Attitudes Examination scale and items assessing the acceptability of gonorrhoea vaccine. Interviews explored deeper perceptions of vaccination, trust and delivery preferences. Quantitative data were analysed descriptively and qualitative data thematically using Braun and Clarke's framework. Results: Participants showed high general vaccine confidence, with 92.2% strongly supporting a gonorrhoea vaccine programme. Acceptance was driven by concerns about antimicrobial resistance and trust in UK regulatory systems. Stigma and structural barriers, such as fear of judgement, cost and inconvenient delivery settings, were key factors influencing access. Participants favoured delivery through sexual health clinics and LGBTQ+ venues and strongly endorsed peer-led outreach. Partial efficacy of the proposed vaccine was accepted when transparently communicated. Concerns over personal costs emerged as potentially worsening inequalities. Conclusions: While overall acceptability was high, successful uptake requires delivery that is trusted, stigma-free, accessible and clearly communicated. Policy recommendations include ensuring free access, leveraging peer-led campaigns and delivering vaccination in low-barrier settings. Monitoring by demographic group is essential to prevent inequities. These insights are crucial as the UK's pioneering programme generates global evidence for future STI vaccine policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.